Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?
Background Since schizophrenia is considered one of the top ten causes of disease-related disability in the world, the development of second-generation (atypical) antipsychotics (SGAs) has increased the hopes of psychiatrists. SGAs, however, cannot be considered a unique pharmacological class since...
Main Authors: | Chiara Mattei, Maria Paola Rapagnani, Stephen M. Stahl |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-01-01
|
Series: | Journal of Central Nervous System Disease |
Online Access: | https://doi.org/10.4137/JCNSD.S4138 |
Similar Items
-
Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?
by: Chiara Mattei, et al.
Published: (2011-02-01) -
Efficacy of ziprasidone and risperidone in treatment of vagrants with schizophrenia
by: Zhan-Hua Li, et al.
Published: (2016-06-01) -
Half Uniformity dosage of Metformin hydrocloride in tablets of different brands
by: E. F Souza, et al.
Published: (2016-05-01) -
Half Uniformity dosage of Metformin hydrocloride in tablets of different brands
by: C. L. Oliveira, et al.
Published: (2016-04-01) -
Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia
by: Andrea Fagiolini, et al.
Published: (2011-11-01)